The largest database of trusted experimental protocols

8 protocols using cp 724714

1

Evaluating HDAC Inhibitors and EGFR/HER2 Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDAC inhibitors (HDACi) CUDC-101 [19 (link)], Pracinostat [36 (link)], MGCD0103 [37 (link)], MC1568 [38 (link)] and PCI-34051 [39 (link)] were purchased from Selleck Chemicals. The specific inhibitors of EGFR and HER2/NEU, Gefitinib [40 (link)] and CP-724714 [41 (link)], were also purchased from Selleck. Sodium Butyrate [42 (link)] was purchased from Sigma Aldrich. All HDACi were used at published IC50. Gefitinib and CP-724714 were used at a range of concentrations (108-540 nM and 108-864 nM, respectively). In the experiments determining IC50, dose response and time course activity against AR-V7 and flAR activity (Fig. 1), CUDC-101 was used between 0.3 nM to 1 uM from 3 to 24 hours. It was used at a concentration of 300 nM for 6 or 24 hours in the remaining experiments, unless stated otherwise. All reagents were dissolved in DMSO, except DHT, which was dissolved in ethanol.
+ Open protocol
+ Expand
2

Targeted Modulation of HER2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The siRNA targeting JWA (5′-CGAGCTATTTCC TTATCTC-3′) and a scrambled control siRNA (RiboBio, Guangzhou, China) were transfected into cells using Lipofectamine 2000 (Invitrogen, Grand Island, USA). A HER2 short hairpin RNA (shRNA) (GenePharma, China) was constructed by subcloning the siRNA expression cassettes into the pGPU6/GFP/Neo vector. The origins of the Vector and FLAG-JWA plasmids have been previously described [17 (link)]. The HER2 wild-type (HER2 WT) construct was obtained from Mien-Chie Hung (Addgene, INSERT CITY, USA). The plasmids were transiently transfected into NCI-N87 cells using the Lipofectamine 3000 transfection reagent (Invitrogen, USA) according to the manufacturer's protocol. Her2 inhibitor CP724714, MEK-inhibitor U0126 and PI3K inhibitor LY294002 were purchased from Selleck Chemicals (Houston, USA). Epidermal Growth Factor (EGF) was purchased from PeproTech (Rocky Hill, USA).
+ Open protocol
+ Expand
3

Cell Line Cultivation and Inhibitor Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-BR-3, A431, NIH-3T3 and A549 cell lines (American Type Culture Collection) were grown in DMEM or DMEM-F12 medium supplemented with 10% FCS at 37 °C in an humidified atmosphere of 5% CO2. Cells were cultured up to passage 30. Thapsigargin (Sigma-Aldrich) is used at 1 μm. Lapatinib (2μM), CP-724714 (2μM), MK-2206 (1μM) and trametinib (10μM) were purchased from Selleckchem. LY294002 (25μM), gefitinib (1μM), and erlotinib (5μM) were provided by Tocris, ruxolitinib (1μM) by VWR and trastuzumab (1μM) by Roche.
+ Open protocol
+ Expand
4

HER2 Inhibitor Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2 inhibitor CP-724714 was from Selleckchem (Houston, TX, USA). Normal human IgG were purchased from Sigma-Aldrich (St. Louis, MO, USA). Trastuzumab was from Roche (Basel, Switzerland). Mouse monoclonal antibodies to human EGFR (1005), HER2 (A-2) (sc-393712), human EGFR (1005), Akt1/2 (H-136), Erk1/2 (k-23), pT202/Y204 Erk1/2 were from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Rabbit monoclonal antibodies to phospho-Akt (Ser473) and phosphor(Thr308), and rabbit monoclonal antibody to HER2/ErbB2 (29D8) were purchased from Cell Signaling Technology (Danvers, MA, USA). Rabbit polyclonal antibodies to phospho-HER2 Y-1005, Y-1112, Y-1127, Y-1139, Y-1196, and Y-1248 were from FroggaBio (Toronto, ON, Canada). Secondary antibodies used for Western analysis, including Anti-rabbit and anti-mouse RDye® 800 CW and RDye® 650, were from LI-COR biotechnology Inc. (Lincoln, NE, USA). Invitrogen™ Cholera Toxin Subunit B (Recombinant) and Alexa Fluor™ 488 Conjugate were purchased from Fisher Scientific (Ottawa, ON, Canada). All other chemicals were purchased from Sigma-Aldrich (Oakville ON, Canada).
+ Open protocol
+ Expand
5

Signaling Pathway Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture media, phosphate buffered saline, and fetal bovine serum were obtained from Invitrogen (Gibco, Karlsruhe, Germany). Antibodies against Akt, phospho-Akt, p44/42 MAPK, phospho-p44/42 MAPK, actin, and anti-mouse IgG Alexa Fluor® 647 (#4410S) were purchased from Cell Signaling (Danvers, MA, USA). Anti-HER3 purified antibody (clone 1B4C3) was purchased from BioLegend®. Secondary antibodies were from Sigma–Aldrich (Steinheim, Germany). Protran Nitrocellulose Transfer membranes were purchased from Whatman (Dassel, Germany). The enhanced chemiluminescence systems (Super Signal West Femto Maximum Sensitivity Substrate and SuperSignal West Pico Chemiluminescent Substrate) were from Thermo-Scientific (Bonn, Germany). The WST-1 kit was from Roche Applied Science (Mannheim, Germany). The PCK inhibitor bisindolylmaleimide II (BIM II), the MET inhibitor PF04217903, and the HER1 inhibitor AG1478 were from Tocris (Wiesbaden, Germany). The HER2 inhibitor CP724714 was purchased from Selleckchem (Munich, Germany). Heregulin and 12-O-Tetradecanoylphorbol 13-acetate (PKC activator, PMA) were obtained from Sigma–Aldrich (Steinheim, Germany). The human phospho-MAPK Array Kit was from R&D (Minneapolis, MN, USA). All other chemicals used were purchased from Carl Roth (Karlsruhe, Germany) unless indicated otherwise.
+ Open protocol
+ Expand
6

Cell Culture Supplies and Compound Sourcing

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased all cell culture supplies from Life Technologies (Carlsbad, CA) unless otherwise stated. We obtained drugs, compounds, and hormone supplements from the following sources: AG-490, PD0325901, CP724714, MK-2206 2HCl, MK-8669, GDC-0941, BazedoxifeneHCl, Trametinib (GSK112021), and Fulvestrant from SelleckChem (Houston, TX); AMD3100 from Tocris Bioscience (Bristol, UK); SB-431542 from Cayman Chemical (Ann Arbor, MI), 4-hydroxytamoxifen and β-estradiol from Sigma Aldrich (St. Louis, MO); and cisplatin (NDC-0703-5748-11), paclitaxel (NDC-55390-304-50), and doxorubicin (NDC-0069-3030-20) from the University of Michigan Hospital Pharmacy as clinical formulations. We prepared 10 mM stocks of estrogen in ethanol, while we used other compounds in formulations supplied or specified by manufacturers. d-Luciferin was from Promega (Madison, WI).
+ Open protocol
+ Expand
7

Molecular Profiling of HER2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2 kinase inhibitor CP-724714 was purchased from Selleckchem (Houston, TX, USA). Pertuzumab (Perjeta®) and trastuzumab (Hercepton®) were purchased from Hoffmann-La Roche (Basel, Switzerland). Mouse monoclonal anti-human HER2 (9G6) (sc-08), anti-human HER2 (A-2) (sc-393712), anti-human EGFR (A-10) (sc-373746), anti-human HER3 (RTJ.2) (sc-415), and rabbit polyclonal anti-human pY1248 HER2 (sc-12352-R) antibodies were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Rabbit polyclonal anti-human pY1005, pY1112, pY1127, pY1139, and pY1196 HER2 were purchased from FroggaBio (Toronto, ON, Canada) and mouse monoclonal anti-human pY1221/1222 HER2 (6B12) (2243) were from Cell Signaling Technology (Danvers, MA, USA). Anti-rabbit and anti-mouse RDye® 800CW and RDye® 650 secondary antibodies were purchased from LI-COR biotechnology Inc. (Lincoln, NE, USA). Isotype control human IgG and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
8

Mutp53 Breast and Colon Cells Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mutp53 breast cancer cells MDA231 (p53R280K), MDA468 (p53R273K), T47D (p53L194F), SKBr3 (p53R175H), colon cancer cells SW480 (p53 R273H/P309S) and isogenic HCT116 p53−/− vs wtp53+/+ cells were used. Generation of stable Tet-On shp53 MDA231 was described.9 (link) MDA231 and SKBr3 stably overexpressing native ectopic p53 (R280K and R175H) or vector only were generated by transfection followed by selection in G418. All cells were cultured in 10% FCS/DMEM and where indicated treated with CP724714 (Selleckchem, Huston, TX, USA), UO126, LY294002 (LC Labs, Woburn, MA, USA) and Camptothecin (Sigma, St. Louis, MO, USA). Viability was determined using CellTiter-Blue Assay, and HSF1 activity using Dual-Luciferase Reporter Assay (Promega, Madison, WI, USA) with the Hsp70 HSE-Luc reporter (Qiagen, Valencia, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!